Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sarah M. Talamantes
Systematic Review and Meta-Analysis of Selected Toxicities of Approved ALK Inhibitors in Metastatic Non-Small Cell Lung Cancer
Oncotarget
Oncology
Related publications
Tackling ALK in Non-Small Cell Lung Cancer: The Role of Novel Inhibitors
Translational Lung Cancer Research
Oncology
Efficacy of EGFR-TKIs With or Without Angiogenesis Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Journal of Cancer
Oncology
New Options in the Management of Intractable ALK(+) Metastatic Non-Small-Cell Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
Addition of Bevacizumab to Chemotherapy in Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
Clinicopathological Significance of DAPK Promoter Methylation in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Cancer Management and Research
Oncology
Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Brigatinib for ALK-positive Metastatic Non-Small-Cell Lung Cancer: Design, Development and Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Anaplastic Lymphoma Kinase (ALK) Inhibitors for Second-Line Therapy of Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary